More reads

• The FDA disagrees with its own expert panels how often? (STAT Plus)
• AI drug hunters could give Big Pharma a run for its money. (Bloomberg)
• The promise and price of cellular therapies. (New Yorker)
• Scientists close in on blood test for Alzheimer’s. (STAT)